We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Database Giants Announce Strategic Partnership

By Biotechdaily staff writers
Posted on 20 Feb 2007
Genomatix Software GmbH (Munich, Germany) and Molecular Connections Private Ltd., (Bangalore, India) recently announced the formation of a strategic partnership in the field of biotechnology information management. More...


Genomatix employs a multi-layer integrative approach that combines sequence analysis, functional promoter analysis, proprietary genome annotation, promoter sequence databases, comparative genomics, scientific literature data mining, pathway databases, biologic network databases, pathway analysis, network analysis, and expression profiling. Molecular Connections provides text mining, literature curation, and annotation services as well as products. It claims specific expertise in building knowledge bases for rapidly growing genomics, proteomics, and related areas.

The new partnership will fully integrate Molecular Connections Netpro database into Genomatix's biologic networks and pathway knowledge base and analysis system BiblioSphere PathwayEdition (BSPE). Netpro is reputed to be one of the largest expert curated databases of protein-protein and protein-small molecule interactions in the world and contains highly granular contextual data on nature of interaction, pathways, diseases, location, plus pharmacokinetics information related to the interactions. BSPE's database is created from millions of individually modeled relationships between genes, proteins, complexes, cells, and tissues.

"I am absolutely delighted by this partnership with Molecular Connections,” said Dr. Thomas Werner, CEO of Genomatix. "By it we are able to combine the best of two worlds: large scale text mining and our expert knowledge of gene regulation with the unbeatable expert curation of Molecular Connection's expert scientists. In my eyes this is a perfect match. From all what I have seen, Molecular Connections adheres to the same rigorous quality standards as Genomatix does.”

Mr. Jignesh Bhate, CEO of Molecular Connections remarked, "We are happy to be associated with Genomatix. We believe NetPro will provide significant value to the existing and future users of BSPE.”





Related Links:
Genomatix Software GmbH
Molecular Connections Private Ltd.

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
All-in-One Molecular System
AIO M160
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.